Results 201 to 210 of about 32,436 (310)
Case History of a Mental Health Clinic [PDF]
openaire +2 more sources
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz +9 more
wiley +1 more source
A Qualitative Study of the Medical Student's Perception on Sexual Violence and its Determinants in the Society. [PDF]
Veena V +4 more
europepmc +1 more source
Social Suffering, Gender, And Women\u27s Depression [PDF]
Marecek, Jeanne
core +2 more sources
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht +53 more
wiley +1 more source
The Folk Concept of Nursing in Australia: A Decolonising Conceptual Analysis. [PDF]
Mackay J +4 more
europepmc +1 more source
“Donkeys” or “Lions”? Re-Examining Great War Stereotypes [PDF]
Vance, Jonathan F.
core +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Systematic literature review on biopsychosocial factors in the surgical waiting list. [PDF]
Silva-Aravena F, Morales J, Canales LL.
europepmc +1 more source
ABSTRACT The Clinical Assessment Scale in Autoimmune Encephalitis (CASE) tracks disease severity in autoimmune encephalitis (AE), but no threshold for significant change exists. We aimed to determine the minimally clinically important difference (MCID) for CASE.
Yihui Goh +8 more
wiley +1 more source

